Abstract：With the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) all over the world, there is an increasing number of children with such infection. Angiotensin-converting enzyme 2 (ACE2), one of the binding sites for SARS-CoV-2 infection in humans, can bind to viral spike proteins, allowing transmembrane serine protease (TMPRSS2) to activate S-protein to trigger infection and induce the production of various inflammatory factors such as interleukin-1, interferon-l, and tumor necrosis factor. Compared with adults, children tend to have lower expression levels of ACE2 and TMPRSS2, which are presumed to be associated with milder symptoms and fewer cases in children. The article summarizes the research advances in the role of ACE2 during SARS-CoV-2 infection, in order to help understand the pathogenic mechanism of SARS-CoV-2 and provide a reference for better development of drugs and vaccines to prevent and treat coronavirus disease 2019 in children.
LIU Jing,CHEN Guo-Qian,WEI Li et al. A review on the role of angiotensin-converting enzyme 2 in children with coronavirus disease 2019[J]. CJCP, 2020, 22(12): 1344-1348.
Ding Q, Lu P, Fan Y, et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China[J]. J Med Virol, 2020, 92(9):1549-1555.
World Health Organization. Coronavirus disease (COVID-19):data as received by WHO from national authorities, as of 04 October 2020, 10 am CEST[EB/OL].[2020-10-05]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf.
[4]
Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein[J]. Cell, 2020, 181(2):281-292.e6.
[5]
Saheb Sharif-Askari N, Saheb Sharif-Askari F, Alabed M, et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD[J]. Mol Ther Methods Clin Dev, 2020, 18:1-6.
[6]
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019(COVID-19) outbreak in China:summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13):1239-1242.
Cao Q, Chen YC, Chen CL, et al. SARS-CoV-2 infection in children:transmission dynamics and clinical characteristics[J]. J Formos Med Assoc, 2020, 119(3):670-673.
[11]
Su L, Ma X, Yu H, et al. The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19[J]. Emerg Microbes Infect, 2020, 9(1):707-713.
[12]
Shen KL, Yang YH, Jiang RM, et al. Updated diagnosis, treatment and prevention of COVID-19 in children:experts' consensus statement (condensed version of the second edition)[J]. World J Pediatr, 2020, 16(3):232-239.
He H, Zhao S, Han L, et al. Anesthetic management of patients undergoing aortic dissection repair with suspected severe acute respiratory syndrome COVID-19 infection[J]. J Cardiothorac Vasc Anesth, 2020, 34(6):1402-1405.
[16]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8):727-733.
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci, 2020, 63(3):457-460.
[21]
Liu WZ, Li HL. COVID-19:attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit heme metabolism[J]. Am Chem Soc, 2020. DOI:10.26434/chemrxiv.11938173. Online ahead of print.
[22]
Chen IM, Loh JP, Chuah CXP, et al. Evidence for cross-protection against subsequent febrile respiratory illness episodes from prior infections by different viruses among Singapore military recruits 2009-2014[J]. J Infect Dis, 2019, 219(12):1913-1923.
[23]
Weintraub B. Upper respiratory tract infections[J]. Pediatr Rev, 2015, 36(12):554-556.
[24]
Day CW, Baric R, Cai SX, et al. A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo[J]. Virology, 2009, 395(2):210-222.
[25]
Santos RAS, Oudit GY, Verano-Braga T, et al. The renin-angiotensin system:going beyond the classical paradigms[J]. Am J Physiol Heart Circ Physiol, 2019, 316(5):H958-H970.
[26]
Bitker L, Burrell LM. Classic and nonclassic renin-angiotensin systems in the critically ill[J]. Crit Care Clin, 2019, 35(2):213-227.
[27]
Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase[J]. J Biol Chem, 2000, 275(43):33238-33243.
[28]
Kuba K, Imai Y, Penninger JM. Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases[J]. Circ J, 2013, 77(2):301-308.
[29]
Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system:focus on angiotensin-(1-7)[J]. Physiol Rev, 2018, 98(1):505-553.
[30]
Turner AJ, Tipnis SR, Guy JL, et al. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors[J]. Can J Physiol Pharmacol, 2002, 80(4):346-353.
[31]
de Lang A, Osterhaus AD, Haagmans BL. Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells[J]. Virology, 2006, 353(2):474-481.
[32]
Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2[J]. Circulation, 2005, 111(20):2605-2610.
[33]
Klimas J, Olvedy M, Ochodnicka-Mackovicova K, et al. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats[J]. J Cell Mol Med, 2015, 19(8):1965-1974.
[34]
Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure[J]. Nature, 2005, 436(7047):112-116.
Hanff TC, Harhay MO, Brown TS, et al. Is there an association between COVID-19 mortality and the renin-angiotensin system? a call for epidemiologic investigations[J]. Clin Infect Dis, 2020, 71(15):870-874.
[39]
Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury[J]. Sci China Life Sci, 2020, 63(3):364-374.
[40]
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19[J]. Lancet, 2020, 395(10234):1417-1418.
[41]
Liu H, Gai S, Wang X, et al. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart[J]. Cardiovasc Res, 2020, 116(10):1733-1741.
[42]
Ma CX, Cong YZ, Zhang H. COVID-19 and the digestive system[J]. Am J Gastroenterol, 2020, 115(7):1003-1006.
[43]
Zhang YM, Zhang H. Genetic roadmap for kidney involvement of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection[J]. Clin J Am Soc Nephrol, 2020, 15(7):1044-1046.
[44]
Pan XW, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak:a study based on single-cell transcriptome analysis[J]. Intensive Care Med, 2020, 46(6):1114-1116.
[45]
Liu J, Ji H, Zheng W, et al. Sex differences in renal angiotensin converting enzyme 2(ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent[J]. Biol Sex Differ, 2010, 1(1):6.
[46]
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224):565-574.
[47]
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J]. Nature, 2003, 426(6965):450-454.
[48]
Kumar S, Maurya VK, Prasad AK, et al. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)[J]. Virusdisease, 2020, 31(1):13-21.
[49]
Shieh WJ, Hsiao CH, Paddock CD, et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan[J]. Hum Pathol, 2005, 36(3):303-309.
[50]
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2(ACE2) in SARS coronavirus-induced lung injury[J]. Nat Med, 2005, 11(8):875-879.
[51]
Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice[J]. Exp Physiol, 2008, 93(5):543-548.
[52]
Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS[J]. Lancet, 2004, 363(9427):2122-2127.
[53]
Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice[J]. Proc Natl Acad Sci U S A, 2004, 101(17):6641-6646.
[54]
Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route:CD147-spike protein[EB/OL]. bioRxiv. (2020-3-14)[2020-07-15]. https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1.
[55]
Ashary N, Bhide A, Chakraborty P, et al. Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2[J]. Front Cell Dev Biol, 2020, 8:783.
